FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells

Cell Biology International

Volumn 41, Issue 1, 2017, Pages 102-110

  Oskay Halacli, Sevil ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

breast cancer; cell migration; FOXP1; NFAT

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN; NFAT1 PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; DNA; FOXP1 PROTEIN, HUMAN; LUCIFERASE; NFATC2 PROTEIN, HUMAN; PROTEIN BINDING; REPRESSOR PROTEIN;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; MDA MB 231 CELL LINE; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR CELL; WOUND HEALING; BREAST TUMOR; CELL MOTION; CELL NUCLEUS; FEMALE; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; DNA, NEOPLASM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LUCIFERASES; NFATC TRANSCRIPTION FACTORS; PROTEIN BINDING; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 85004008242     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10702     Document Type: Article

References (53)

1. Ackermann S, Kocak H, Hero B, Ehemann V, Kahlert Y, Oberthuer A, Roels F, Theissen J, Odenthal M, Berthold F, Fischer M (2014) FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma. BMC Cancer 14: 840.
2. Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, Jones M, Mason DY, Prime JE, Trougouboff P, Wood K, Cordell JL (2001) The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res 61: 8820–9.
3. Banham AH, Boddy J, Launchbury R, Han C, Turley H, Malone PR, Harris AL, Fox SB (2007) Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Prostate 67: 1091–8.
4. Barnes JA, Dix DJ, Collins BW, Luft C, Allen JW (2001) Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones 6: 316–25.
5. Bates GJ, Fox SB, Han C, Launchbury R, Leek RD, Harris AL, Banham AH (2008) Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas. Breast Cancer Res Treat 111: 453–9.
6. Brown PJ, Ashe SL, Leich E, Burek C, Barrans S, Fenton JA, Jack AS, Pulford K, Rosenwald A, Banham AH (2008) Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. Blood 111: 2816–24.
7. Choi EJ, Seo EJ, Kim DK, Lee SI, Kwon YW, Jang IH, Kim KH, Suh DS, Kim JH (2016) FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Oncotarget 7: 3506–19.
8. de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW (1998) Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182–6.
9. Feng X, Ippolito GC, Tian L, Wiehagen K, Oh S, Sambandam A, Willen J, Bunte RM, Maika SD, Harriss JV, Caton AJ, Bhandoola A, Tucker PW, Hu H (2010) Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. Blood 115: 510–8.
10. Feng X, Wang H, Takata H, Day TJ, Willen J, Hu H (2011) Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat Immunol 12: 544–50.
11. Fox SB, Brown P, Han C, Ashe S, Leek RD, Harris AL, Banham AH (2004) Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas. Clin Cancer Res 10: 3521–7.
12. Garcea G, Ganga R, Neal CP, Ong SL, Dennison AR, Berry DP (2010) Preoperative early warning scores can predict in-hospital mortality and critical care admission following emergency surgery. J Surg Res 159: 729–34.
13. Giatromanolaki A, Koukourakis MI, Sivridis E, Gatter KC, Harris AL, Banham AH (2006) Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression. Mod Pathol 19: 9–16.
14. Gomez GG, Volinia S, Croce CM, Zanca C, Li M, Emnett R, Gutmann DH, Brennan CW, Furnari FB, Cavenee WK (2014) Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity. Cancer Res 74: 1429–39.
15. Grundmann S, Lindmayer C, Hans FP, Hoefer I, Helbing T, Pasterkamp G, Bode C, de Kleijn D, Moser M (2013) FoxP1 stimulates angiogenesis by repressing the inhibitory guidance protein semaphorin 5B in endothelial cells. PLoS ONE 8: e70873.
16. Halacli SO, Dogan AL (2015) FOXP1 regulation via the PI3K/Akt/p70S6K signaling pathway in breast cancer cells. Oncol Lett 9: 1482–8.
17. Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S (2012) Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients. Horm Cancer 3: 147–59.
18. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A (2002) The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4: 540–4.
19. Jiang W, Li L, Tang Y, Zhang WY, Liu WP, Li GD (2012) Expression of FOXP1 in mucosa-associated lymphoid tissue lymphoma suggests a large tumor cell transformation and predicts a poorer prognosis in the positive thyroid patients. Med Oncol 29: 3352–9.
20. Kim TH, Kim HI, Soung YH, Shaw LA, Chung J (2009) Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion. Mol Cancer Res 7: 1605–12.
21. Konstantoulas CJ, Parmar M, Li M (2010) FoxP1 promotes midbrain identity in embryonic stem cell-derived dopamine neurons by regulating Pitx3. J Neurochem 113: 836–47.
22. Koon HB, Ippolito GC, Banham AH, Tucker PW (2007) FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets 11: 955–65.
23. Kuper C, Beck FX, Neuhofer W (2014) NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells. Front Physiol 5: 293.
24. Leishman E, Howard JM, Garcia GE, Miao Q, Ku AT, Dekker JD, Tucker H, Nguyen H (2013) Foxp1 maintains hair follicle stem cell quiescence through regulation of Fgf18. Development 140: 3809–18.
25. Liu JF, Zhao SH, Wu SS (2013) Depleting NFAT1 expression inhibits the ability of invasion and migration of human lung cancer cells. Cancer Cell Int 13: 41.
26. Macian F (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5: 472–84.
27. Muller MR, Rao A (2010) NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 10: 645–56.
28. Palmesino E, Rousso DL, Kao TJ, Klar A, Laufer E, Uemura O, Okamoto H, Novitch BG, Kania A (2010) Foxp1 and lhx1 coordinate motor neuron migration with axon trajectory choice by gating Reelin signalling. PLoS Biol 8: e1000446.
29. Pan MG, Xiong Y, Chen F (2013) NFAT gene family in inflammation and cancer. Curr Mol Med 13: 543–54.
30. Qin J, Xu Y, Li X, Wu Y, Zhou J, Wang G, Chen L (2014a) Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell. Exp Mol Pathol 96: 1–8.
31. Qin JJ, Nag S, Wang W, Zhou J, Zhang WD, Wang H, Zhang R (2014b) NFAT as cancer target: mission possible? Biochim Biophys Acta 1846: 297–311.
32. Rayoo M, Yan M, Takano EA, Bates GJ, Brown PJ, Banham AH, Fox SB (2009) Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers. J Clin Pathol 62: 896–902.
33. Shi C, Zhang X, Chen Z, Sulaiman K, Feinberg MW, Ballantyne CM, Jain MK, Simon DI (2004) Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest 114: 408–18.
34. Shu W, Yang H, Zhang L, Lu MM, Morrisey EE (2001) Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. J Biol Chem 276: 27488–97.
35. Takayama K, Horie-Inoue K, Ikeda K, Urano T, Murakami K, Hayashizaki Y, Ouchi Y, Inoue S (2008) FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Biochem Biophys Res Commun 374: 388–93.
36. Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Takahashi S, Homma Y, Urano T, Aburatani H, Inoue S (2014) Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. Mol Endocrinol 28: 2012–24.
37. Tie X, Han S, Meng L, Wang Y, Wu A (2013) NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells. PLoS ONE 8: e66008.
38. Toma MI, Weber T, Meinhardt M, Zastrow S, Grimm MO, Fussel S, Wirth MP, Baretton GB (2011) Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma. Cancer Invest 29: 123–9.
39. van Boxtel R, Gomez-Puerto C, Mokry M, Eijkelenboom A, van der Vos KE, Nieuwenhuis EE, Burgering BM, Lam EW, Coffer PJ (2013) FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis. Cell Death Differ 20: 1219–29.
40. Wang B, Lin D, Li C, Tucker P (2003) Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J Biol Chem 278: 24259–68.
41. Wang B, Weidenfeld J, Lu MM, Maika S, Kuziel WA, Morrisey EE, Tucker PW (2004) Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 131: 4477–87.
42. Wang H, Geng J, Wen X, Bi E, Kossenkov AV, Wolf AI, Tas J, Choi YS, Takata H, Day TJ, Chang LY, Sprout SL, Becker EK, Willen J, Tian L, Wang X, Xiao C, Jiang P, Crotty S, Victora GD, Showe LC, Tucker HO, Erikson J, Hu H (2014) The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells. Nat Immunol 15: 667–75.
43. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC, Bates DL, Guo L, Han A, Ziegler SF, Mathis D, Benoist C, Chen L, Rao A (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375–87.
44. Xue L, Yue S, Zhang J (2014) FOXP1 has a low expression in human gliomas and its overexpression inhibits proliferation, invasion and migration of human glioma U251 cells. Mol Med Rep 10: 467–72.
45. Xue ZH, Zhao CQ, Chua GL, Tan SW, Tang XY, Wong SC, Tan SM (2010) Integrin alphaMbeta2 clustering triggers phosphorylation and activation of protein kinase C delta that regulates transcription factor Foxp1 expression in monocytes. J Immunol 184: 3697–709.
46. Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, Jeng YM, Kuo ML, Chang CC (2012) Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 31: 2401–11.
47. Yiu GK, Kaunisto A, Chin YR, Toker A (2011) NFAT promotes carcinoma invasive migration through glypican-6. Biochem J 440: 157–66.
48. Yiu GK, Toker A (2006) NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 281: 12210–7.
49. Yoeli-Lerner M, Chin YR, Hansen CK, Toker A (2009) Akt/protein kinase b and glycogen synthase kinase-3beta signaling pathway regulates cell migration through the NFAT1 transcription factor. Mol Cancer Res 7: 425–32.
50. Yu B, Zhou X, Li B, Xiao X, Yan S, Shi D (2011) FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma. Ann Hematol 90: 701–8.
51. Zhang Y, Li S, Yuan L, Tian Y, Weidenfeld J, Yang J, Liu F, Chokas AL, Morrisey EE (2010) Foxp1 coordinates cardiomyocyte proliferation through both cell-autonomous and nonautonomous mechanisms. Genes Dev 24: 1746–57.
52. Zhang Y, Zhang S, Wang X, Liu J, Yang L, He S, Chen L, Huang J (2012) Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma. J Clin Pathol 65: 528–33.
53. Zhou R, Yu L, Zhou S, Bi R, Shui R, Yu B, Lu H, Cai X, Yang W (2014) Male breast carcinoma: a clinicopathological and immunohistochemical characterization study. Int J Clin Exp Pathol 7: 6852–61.